Research and Development

Events 4 Healthcare has announced two new appointments to enhance the team on the back of a number of new …

Ark Therapeutics has announced that Kassim Kolia has been appointed as head of business development.  In this role, Kolia will …

Sanofi has submitted its multiple sclerosis pill Lemtrada for regulatory reviews in the US and Europe. Lemtrada (alemtuzumab), originally developed …

After completing her PhD in Biochemistry at the University of Aberystwyth in 1982, Jane worked her way up the Johnson …

A round-up of news in the contract research services sector, including updates from Foundation Medicine, Complete Genomics, eResearch Technology, LabCorp …

Lonza has appointed Beat In-Albon as chief operating officer of its Life Science Ingredients sector. In-Albon, 60, becomes a member …

Lilly’s leader is calling on governments to take the long-term view when it comes to healthcare policy. John Lechleiter who …

Frank Lis, Vice President & General Manager, Clinical Supply Services, explores the general effects brought on by the consolidation of …

Roche’s RoActemra (tocilizumab) is more effective in treating rheumatoid arthritis as a single agent than market leader Humira, a new …

Sun Pharma has appointed Israel Makov as its new chairman of the board. Makov is the former president and chief …

Shire has announced the promotion of David Colpman and Ann Judge (pictured) as two senior leaders within the firm.  Colpman, …

Eli Lilly has elected William Kaelin Jr to its board of directors. Dr Kaelin, 54, is a Professor in the Department of …

Workers at Merck Serono’s Swiss headquarters in Geneva have threatened industrial action over the company’s plans to shut down the …

Roche’s new ‘smart bomb’ breast cancer drug T-DM1 has impressed at this year’s ASCO conference in Chicago. The trial showed it …

Bristol-Myers Squibb has formed a network of ten institutions to advance work on using the body’s own immune system to …